These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
340 related articles for article (PubMed ID: 33313997)
1. Molecular probes for the human adenosine receptors. Yang X; Heitman LH; IJzerman AP; van der Es D Purinergic Signal; 2021 Mar; 17(1):85-108. PubMed ID: 33313997 [TBL] [Abstract][Full Text] [Related]
2. Chemical Probes for the Adenosine Receptors. Federico S; Lassiani L; Spalluto G Pharmaceuticals (Basel); 2019 Nov; 12(4):. PubMed ID: 31726680 [TBL] [Abstract][Full Text] [Related]
3. Structure-based approaches to ligands for G-protein-coupled adenosine and P2Y receptors, from small molecules to nanoconjugates. Jacobson KA J Med Chem; 2013 May; 56(10):3749-67. PubMed ID: 23597047 [TBL] [Abstract][Full Text] [Related]
5. Purinergic receptors modulators: An emerging pharmacological tool for disease management. Mahmood A; Iqbal J Med Res Rev; 2022 Jul; 42(4):1661-1703. PubMed ID: 35561109 [TBL] [Abstract][Full Text] [Related]
6. Covalent molecular probes for class A G protein-coupled receptors: advances and applications. Weichert D; Gmeiner P ACS Chem Biol; 2015 Jun; 10(6):1376-86. PubMed ID: 25860503 [TBL] [Abstract][Full Text] [Related]
7. Allosteric modulators for adenosine receptors: an alternative to the orthosteric ligands. La Motta C; Sartini S; Morelli M; Taliani S; Da Settimo F Curr Top Med Chem; 2010; 10(10):976-92. PubMed ID: 20370657 [TBL] [Abstract][Full Text] [Related]
8. New heterocyclic ligands for the adenosine receptors P1 and for the ATP receptors P2. Baraldi PG; Romagnoli R; Tabrizi MA; Bovero A; Preti D; Fruttarolo F; Moorman AR; Borea PA Farmaco; 2005 Mar; 60(3):185-202. PubMed ID: 15784237 [TBL] [Abstract][Full Text] [Related]
10. New paradigms in adenosine receptor pharmacology: allostery, oligomerization and biased agonism. Vecchio EA; Baltos JA; Nguyen ATN; Christopoulos A; White PJ; May LT Br J Pharmacol; 2018 Nov; 175(21):4036-4046. PubMed ID: 29679502 [TBL] [Abstract][Full Text] [Related]
11. Fluorescent probes for G-protein-coupled receptor drug discovery. Iliopoulos-Tsoutsouvas C; Kulkarni RN; Makriyannis A; Nikas SP Expert Opin Drug Discov; 2018 Oct; 13(10):933-947. PubMed ID: 30249143 [TBL] [Abstract][Full Text] [Related]
12. G protein-coupled receptors expressed and studied in yeast. The adenosine receptor as a prime example. Wang X; van Westen GJP; Heitman LH; IJzerman AP Biochem Pharmacol; 2021 May; 187():114370. PubMed ID: 33338473 [TBL] [Abstract][Full Text] [Related]
18. Pharmacophoric models and 3D QSAR studies of the adenosine receptor ligands. Tintori C; Manetti F; Botta M Curr Top Med Chem; 2010; 10(10):1019-35. PubMed ID: 20370655 [TBL] [Abstract][Full Text] [Related]
19. PET Imaging of Adenosine Receptors in Diseases. Li J; Hong X; Li G; Conti PS; Zhang X; Chen K Curr Top Med Chem; 2019; 19(16):1445-1463. PubMed ID: 31284861 [TBL] [Abstract][Full Text] [Related]
20. The structure of the adenosine receptors: implications for drug discovery. Lane JR; Jaakola VP; Ijzerman AP Adv Pharmacol; 2011; 61():1-40. PubMed ID: 21586354 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]